Sarepta Therapeutics, Inc. - Proyeksi bathi mangsa ngarep SRPT

Simbol resmi perusahaan Sarepta (SRPT)

Sarepta Therapeutics, Inc. (SRPT) profit growth relies on the expansion of insurance reimbursements for dystrophy treatment. This revenue projection chart confirms this trend, where the current parameter equals 0.01. The positive momentum is based on a closed-loop system of diagnostics and therapy for rare pathologies. Business stability is ensured by complex patents for orphan drugs and in-house viral vector manufacturing plants.

sarepta.com (SRPT): Bathi forward saka 06.03.2023 nganti 18.11.2026

Rincian analitis lan laporan data perusahaan Sarepta Therapeutics, Inc. (SRPT)

- rega lan prakiraan konsensus rega:
Pambiji fundamental perusahaan:Sarepta Therapeutics, Inc.
Produk dadi Sarepta Corp

Fundamental asset screening requires separating market noise from real business growth rates. By analyzing a company's future yield, an investor assesses expected earnings calculated based on demand forecasts and operational efficiency, which allows for the timely identification of cycle phase shifts. For Sarepta Therapeutics, Inc. (SRPT), such a metric confirms the resilience of the subscription model and guarantees the absence of cash flow gaps.

Pesaing langsung

Bathi sing dikarepake Tempus AI|Proyeksi bathi mangsa ngarep Qiagen|Proyeksi bathi mangsa ngarep IONS|Bathi sing dikarepake RGEN (Repligen Corp.)|Avidity - Bathi mangsa ngarep|CRSP (crisprtx.com) - Bathi forward|WGS: Bathi mangsa ngarep|Proyeksi bathi resik Ultragenyx (RARE)|BEAM: Proyeksi bathi mangsa ngarep|TWST (Twist Bio) - Bathi sing dikarepake|TXG (10xgenomics.com) - Proyeksi bathi mangsa ngarep|Proyeksi bathi mangsa ngarep Intellia Therapeutics, Inc.|Proyeksi bathi mangsa ngarep STOK|Prakiraan bathi perusahaan BioLife Solutions Inc|Bathi sing dikarepake Wave Pharma WVE|Proyeksi bathi mangsa ngarep Maze Therapeutics Corp MAZE|SION - Bathi sing dikarepake|Prime Medicine, Inc. (PRME) - Bathi mangsa ngarep|TSHA (Taysha Gene Therapies, Inc.) - Bathi mangsa ngarep|QURE - Prakiraan bathi perusahaan|MGTX (MeiraGTx Holdings plc) - Proyeksi bathi mangsa ngarep|Bathi mangsa ngarep REGENXBIO Inc. (RGNX)|Bathi sing dikarepake Solid Biosciences (SLDB)|ocugen.com (OCGN) - Proyeksi bathi resik|Proyeksi bathi mangsa ngarep PACB (PacBio Corp)|Penghasilan resik sing dikarepake BNTC|DSGN: Bathi mangsa ngarep|RCKT - Proyeksi bathi mangsa ngarep|Penghasilan resik sing dikarepake 4D Molecular Corp FDMT|Bathi mangsa ngarep Lexeo|Bathi sing dikarepake Korro Bio Inc.|Prakiraan bathi resik EDIT (Editas Medicine)|Bathi sing dikarepake Silence Therapeutics Corp (SLN)|PRQR (ProQR) - Penghasilan resik sing dikarepake|Proyeksi bathi mangsa ngarep CDXS (Codexis, Inc.)|Prakiraan bathi perusahaan sangamo.com (SGMO)|nautilus.bio - Proyeksi bathi mangsa ngarep|Metagenomi (MGX) - Bathi mangsa ngarep|DTIL: Proyeksi bathi mangsa ngarep|Bathi resik sing dikarepake Generation Bio Co (GBIO)|BOLD (Boundless Bio) - Proyeksi bathi mangsa ngarep|Bathi mangsa ngarep Exicure (XCUR)|Bathi sing dikarepake Celsion Corporation (IMNN)|PHIO - Bathi resik sing dikarepake|Mustang Bio Inc - Bathi mangsa ngarep|Proyeksi bathi mangsa ngarep transcodetherapeutics.com RNAZ|Bionano Genomics Inc. - Proyeksi bathi mangsa ngarep|APDN (Applied DNA Sciences) - Prakiraan bathi resik|BLUE (bluebirdbio.com) - Bathi mangsa ngarep|Prakiraan bathi resik IPA|OMGA (omegatherapeutics.com) - Proyeksi bathi mangsa ngarep|Singular Genomics Systems Inc (OMIC) - Prakiraan bathi perusahaan|Proyeksi bathi mangsa ngarep RGLS|Prakiraan bathi perusahaan Syros Pharmaceuticals, Inc.|Bathi sing dikarepake Telesis Bio Inc. TBIO|Bathi resik mangsa ngarep TCON (TRACON Pharmaceuticals Inc.)|Unity Bio - Proyeksi bathi mangsa ngarep